Financials
- Market Capitalization 2.98 B
- Employee 339
- Founded 2016
- CEO N/A
- Website www.veratx.com
- Headquarter Delaware, United States
- FIGI BBG00Q72WYG3
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-10.87
Relación precio/flujo de caja
7 992.14
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1679 | ELVN Enliven Therapeutics, Inc. - Common Stock | 50.87 USD | -0.43% | +1.27% | +11.48% | +146.22% | 3.10 B USD | ||
| 1701 | CLDX Celldex Therapeutics, Inc. - Common Stock | 38.53 USD | -1.48% | +1.39% | +21.47% | +41.45% | 3.02 B USD | ||
| 1736 | IRON Disc Medicine, Inc. - Common Stock | 75.98 USD | -0.80% | -2.71% | +10.02% | +31.02% | 2.90 B USD | ||
| 1822 | QURE uniQure N.V. - Ordinary Shares | 41.10 USD | -3.59% | -1.93% | +48.11% | +181.51% | 2.59 B USD |